Cancer
|

Multimodal, Individualized Radiation Therapy for Gliomas

Institution: Radiologie, Universitätsklinikum Heidelberg
Applicant: Prof. Dr. Laila König
Funding line:
Else Kröner Excellence Fellowships
Prof. Dr. Laila König

The project aims to make radiotherapy for malignant brain tumours (high-grade gliomas) more individualised. While these tumours are now diagnosed on the basis of molecular characteristics, the radiation field is still largely defined using uniform safety margins. For the first time, the project will comprehensively link molecular tumour profiles, advanced MRI and functional brain mapping with the treatment plans and the dose actually delivered. Using a large patient cohort from Heidelberg, it will analyse where tumours recur in relation to the radiation field and which factors can predict this. It will also examine whether brain regions responsible for key functions (such as movement and speech) can be specifically spared during treatment planning without reducing the dose to the tumour. The aim is to develop criteria for tailoring target volume and dose to tumour biology in the future – also as a basis for adaptive, MR-guided radiotherapy. The ultimate goal is a treatment with fewer side effects while maintaining the same efficacy.